INTERNATIONAL PATENT: MISSION THERAPEUTICS LIMITED FILES APPLICATION FOR "N-CYANOPYRROLIDINE DEVIRATIVES HAVING ACTIVITY AS INHIBIOTRS OF UBIQUITIN SPECIFIC PEPTIDASE 30"

GENEVA, Feb. 9 -- MISSION THERAPEUTICS LIMITED (McClintock BuildingGranta ParkCambridge Cambridgeshire CB21 6GP) filed a patent application (PCT/GB2025/051637) for "N-CYANOPYRROLIDINE DEVIRATIVES HAVING ACTIVITY AS INHIBIOTRS OF UBIQUITIN SPECIFIC PEPTIDASE 30" on Jul 22, 2025. With publication no. WO/2026/027857, the details related to the patent application was published on Feb 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KEMP, Ian Mark (c/o Mission Therapeutics LimitedMcClintock BuildingGranta ParkCambridge Cambridgeshire CB21 6GP), ALANINE, Thomas (c/o Mission Therapeutics Limited...